Integral Diagnostics Limited (ASX:IDX)
Australia · Delayed Price · Currency is AUD 2.560
-0.020 (-0.78%)
Nov 14, 2025, 9:59 AM AEST
Integral Diagnostics Market Cap
Integral Diagnostics has a market cap or net worth of 954.14 million as of November 13, 2025. Its market cap has increased by 36.42% in one year.
Market Cap
954.14M
Enterprise Value
1.49B
Revenue
627.22M
Ranking
n/a
PE Ratio
169.95
Stock Price
2.56
Market Cap Chart
Since October 21, 2015, Integral Diagnostics's market cap has increased from 263.77M to 954.14M, an increase of 261.73%. That is a compound annual growth rate of 13.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2025 | 954.14M | -11.81% |
| Dec 31, 2024 | 1.08B | 143.25% |
| Dec 29, 2023 | 444.76M | -34.84% |
| Dec 30, 2022 | 682.57M | -31.87% |
| Dec 31, 2021 | 1.00B | 16.26% |
| Dec 31, 2020 | 861.69M | 15.95% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 86.55B |
| Pro Medicus | 26.88B |
| Cochlear | 18.75B |
| Sonic Healthcare | 10.44B |
| Ramsay Health Care | 7.08B |
| Ansell | 5.24B |
| Telix Pharmaceuticals | 5.05B |
| Mesoblast | 3.00B |